Poseida Therapeutics Historical PE Ratio image   This PSTX PE ratio history page last updated 3/21/2024
Poseida Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/7/2024
3.43-0.27-1.08NA
Q3 2023
11/9/2023
2.20-0.35-1.40NA
Q2 2023
8/8/2023
1.98-0.32-1.28NA
Q1 2023
5/9/2023
3.40-0.45-1.80NA
Q4 2022
3/9/2023
5.05-0.39-1.56NA
Q3 2022
11/10/2022
4.500.923.681.2
Q2 2022
8/11/2022
4.11-0.69-2.76NA
Q1 2022
5/12/2022
1.87-0.93-3.72NA
Q4 2021
3/10/2022
3.500.020.0843.8
Q3 2021
11/9/2021
6.76-0.68-2.72NA
Q2 2021
8/12/2021
8.78-0.74-2.96NA
Q1 2021
5/11/2021
8.50-0.62-2.48NA
Q4 2020
3/11/2021
9.80-0.58-2.32NA
Q3 2020
11/12/2020
10.64-0.63-2.52NA
Q2 2020
8/20/2020
9.11-2.28-9.12NA
Poseida Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/7/2024
3.43-0.27-0.94NA
Q3 2023
11/9/2023
2.20-0.35-1.51NA
Q2 2023
8/8/2023
1.98-0.32-0.24NA
Q1 2023
5/9/2023
3.40-0.45-0.61NA
Q4 2022
3/9/2023
5.05-0.39-1.09NA
Q3 2022
11/10/2022
4.500.92-0.68NA
Q2 2022
8/11/2022
4.11-0.69-2.28NA
Q1 2022
5/12/2022
1.87-0.93-2.33NA
Q4 2021
3/10/2022
3.500.02-2.02NA
Q3 2021
11/9/2021
6.76-0.68-2.62NA
Q2 2021
8/12/2021
8.78-0.74-2.57NA
Q1 2021
5/11/2021
8.50-0.62-4.11NA
Q4 2020
3/11/2021
9.80-0.58NANA
Q3 2020
11/12/2020
10.64-0.63NANA
Q2 2020
8/20/2020
9.11-2.28NANA
Quotes delayed 20 minutes

Email EnvelopeFree PSTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Poseida Therapeutics (PSTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PTCT PE Ratio History
PTE PE Ratio History
PTGX PE Ratio History
PTIX PE Ratio History
PTPI PE Ratio History
PULM PE Ratio History
PYXS PE Ratio History
QDEL PE Ratio History
QLGN PE Ratio History
QNCX PE Ratio History
How should the PSTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Poseida Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PSTX Historical PE Ratio page.

What is the average historical PE for PSTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PSTX historical PE ratio using the annualized quarterly earnings method works out to 22.5.

What is the average historical PE for PSTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PSTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Poseida Therapeutics Historical PE Ratio information for Poseida Therapeutics' stock. The average PSTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 22.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PSTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PSTX historical PE result, against the recent PE: when this page was posted on 3/20/2024, the most recent closing price for PSTX had been 2.97, and the most recent quarterly earnings result, annualized, was 3.68. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent PSTX PE on 3/20/2024 based on annualized quarterly EPS was 0.8. Based on PSTX's history, that recent PE is low relative to the historical average, with the recent PE 96.4% lower than the historical average PE across our data set for Poseida Therapeutics.

For self directed investors doing their due diligence on PSTX or any other given stock, valuation analysis for PSTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Poseida Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PSTX. Thanks for visiting, and the next time you need to research PSTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: SYTL Videos, USA Historical Stock Prices, VV Options Chain.

 

Poseida Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.